InspireMD this week registered for a $24.8 million Series C round, with funding slated to support sales and new product development.
The Boston-based company will offer 1.1 million shares of Series C convertible preferred stock and warrants to purchase an additional 4.6 million shares of common stock.
Each share of preferred stock to be offered in the round will include Series B warrants to purchase 4 additional shares of common stock. The Series B warrants will have an exercise price equal to the conversion price of the preferred stock shares offered in the round.
